CLOSE CORRELATION BETWEEN NITRIC-OXIDE (NO) FORMATION FROM NO RELEASERS AND THE BIOLOGICAL-ACTIVITIES OF THESE AGENTS IN RATS

被引:13
作者
KITA, Y
FUKUYAMA, S
HIRASAWA, Y
机构
[1] FUJISAWA PHARMACEUT CO LTD,NEW DRUG RES LABS,YODOGAWA KU,OSAKA 532,JAPAN
[2] FUJISAWA PHARMACEUT CO LTD,ANALYT RES LABS,YODOGAWA KU,OSAKA 532,JAPAN
关键词
FK409; 3-MORPHOLINOSYDNONIMINE (SIN-1); SODIUM NITROPRUSSIDE (SNP); NITRIC OXIDE (NO);
D O I
10.1254/jjp.69.69
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to clarify the difference in the profiles of nitric oxide (NO) formation of three NO releasers and to examine the correlation between NO formation from these drugs and their biological activities in rats. (+/-)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (FK409) and 3-morpholinosydnonimine (SIN-1) spontaneously generated nitrite, an oxidative product of NO, in sodium phosphate buffer (PB) solution. On the other hand, sodium nitroprusside (SNP) did not generate nitrite. The rank order of the concentrations of nitrite generated was SIN-1 > FK409 >> SNP. In biological studies using rats, these drugs showed anti-platelet effects and in vitro vasorelaxant and hypotensive effects with potencies in the rank order of FK409 > SIN-1 > SNP and SNP > FK409 > SIN-1, respectively. These drugs generated nitrite with concentrations in the rank order of FK409 > SIN-1 > SNP and SNP > FK409 > SIN-1 in rat plasma and in PB solution with L-cysteine (Cys), respectively. In conclusion, three NO releasers liberate NO with NO-releasing rates of different rank orders under different incubation conditions, and the anti-platelet effects and vasorelaxant and hypotensive effects of these NO releasers closely correlate with NO formation from the compounds in the plasma and PB solution with Cys, respectively, but not with that in PB solution without Cys.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 18 条
[1]  
[Anonymous], 2006, J PHYSIOL-LONDON, DOI DOI 10.1113/jphysiol.2006.116632
[2]   NITRIC-OXIDE GENERATION FROM NITROPRUSSIDE BY VASCULAR TISSUE - EVIDENCE THAT REDUCTION OF THE NITROPRUSSIDE ANION AND CYANIDE LOSS ARE REQUIRED [J].
BATES, JN ;
BAKER, MT ;
GUERRA, R ;
HARRISON, DG .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 :S157-S165
[3]   DETERMINATION OF OIL/WATER DISTRIBUTION COEFFICIENTS OF GLYCERYL TRINITRATE AND 2 SIMILAR NITRATE ESTERS [J].
BELL, FK ;
BURGISON, RM ;
ONEILL, JJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (07) :637-&
[4]  
BOHN H, 1989, J CARDIOVASC PHA S11, V14, P6
[5]  
BORN GV, 1968, J PHYSL, V168, P178
[7]   NITRIC-OXIDE (NO) FORMATION FROM NITROVASODILATORS OCCURS INDEPENDENTLY OF HEMOGLOBIN OR NONHEME IRON [J].
FEELISCH, M ;
NOACK, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 142 (03) :465-469
[8]   CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30
[9]   INHIBITION OF PLATELET ACTIVATING FACTOR-INDUCED PLATELET-AGGREGATION BY MOLSIDOMINE, SIN-1, AND NITRATES INVITRO AND EXVIVO [J].
GERZER, R ;
DRUMMER, C ;
KARRENBROCK, B ;
HEIM, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 :S115-S119
[10]   FK409, A NOVEL VASODILATOR ISOLATED FROM THE ACID-TREATED FERMENTATION BROTH OF STREPTOMYCES-GRISEOSPOREUS .1. TAXONOMY, FERMENTATION, ISOLATION, AND PHYSICOCHEMICAL AND BIOLOGICAL CHARACTERISTICS [J].
HINO, M ;
IWAMI, M ;
OKAMOTO, M ;
YOSHIDA, K ;
HARUTA, H ;
OKUHARA, M ;
HOSODA, J ;
KOHSAKA, M ;
AOKI, H ;
IMANAKA, H .
JOURNAL OF ANTIBIOTICS, 1989, 42 (11) :1578-1583